The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of INCB040093, a PI3Kδ inhibitor, alone or in combination with INCB039110, a selective JAK1 inhibitor: Interim results from patients (pts) with relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL).
 
Andres Forero-Torres
Research Funding - Incyte (Inst)
 
Paul M. Barr
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics; TG Therapeutics
Research Funding - Pharmacyclics
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Celgene; Idera; Immunogen; Immunogen; Janssen Oncology; Seagen
Speakers' Bureau - Gilead Sciences; Seagen
Research Funding - Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Molecular Templates (Inst); Seagen (Inst)
 
Taimur Sher
Consulting or Advisory Role - Janssen
 
Richard Schaub
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Li Zhou
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Jennifer Pulini
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Lance Leopold
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Matthew A. Spear
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Moshe Talpaz
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Research Funding - ARIAD; Incyte; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - ARIAD; Incyte; Novartis; Pfizer
 
Tycel Jovelle Phillips
No Relationships to Disclose